Five years ago, California voters overwhelmingly chose to legalize the adult use of marijuana. The passage of Proposition 64 was supposed to replace the state’s vast illegal and quasi-legal medical marijuana market, in which virtually anyone could get their hands on marijuana, with a tightly controlled system of safe... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Rand Paul’s festivus marijuana banking slam on Dems; DEA’s drug emoji guide for parents; Robbery preparedness for cannabis dispensaries Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes... Read more
The Drug Enforcement Administration (DEA) says it’s cracked the code to identify what kind of emojis young people are using to talk about buying and selling illicit drugs. But in classic “how do you do fellow kids” fashion, the federal agency doesn’t appear to have the firmest grasp on... Read more
“There may not be much product available after the first couple of days, for several weeks.” By Max Savage Levenson, Montana Free Press On January 1, 2022, adult-use recreational marijuana will become available for purchase in Montana. The launch of the new market raises a wide range of questions,... Read more
Rand Paul’s festivus marijuana banking slam on Dems; DEA’s drug emoji guide for parents; Robbery preparedness for cannabis dispensaries Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes... Read more
MindMed announces that the FDA has placed “clinical hold” on its initial IND submission in preparation for its Phase 2b clinical trial for generalized anxiety disorder (GAD).